These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 5531032

  • 1. [Preparation of the 3d component of guinea pig cmplement (C3)].
    Takahashi S, Okada H, Nishioka K.
    Arerugi; 1970 Dec; 19(12):859-67. PubMed ID: 5531032
    [No Abstract] [Full Text] [Related]

  • 2. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
    Brade V, Nicholson A, Lee GD, Mayer MM.
    J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
    [No Abstract] [Full Text] [Related]

  • 3. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q.
    Volanakis JE, Kaplan MH.
    J Immunol; 1974 Jul; 113(1):9-17. PubMed ID: 4208926
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An improved method for separation of the fourth component of complement and C4 inactivating substance.
    Shimada K, Mayumi M, Sekine T, Nishioka K.
    Jpn J Exp Med; 1972 Oct; 42(5):423-34. PubMed ID: 4539210
    [No Abstract] [Full Text] [Related]

  • 10. C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis.
    Thompson RA.
    Immunology; 1972 Jan; 22(1):147-58. PubMed ID: 4622449
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preparation and characterization of the monospecific antiserum directed to the ninth component of human complement (C9).
    Kawachi-Takahashi S, Tanaka K, Takahashi M.
    Jpn J Exp Med; 1974 Jun; 44(3):283-90. PubMed ID: 4215913
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Separation of the 2nd component of complement (C' 2) from guinea pig serum].
    Shiraishi S.
    Arerugi; 1968 Aug; 17(8):639-45. PubMed ID: 5705551
    [No Abstract] [Full Text] [Related]

  • 16. Isolation and characterization of a trypsin-cleaved fragment derived from the third component of guinea pig complement bound to zymosan.
    Takahashi M, Takahashi S, Motonishi K.
    Jpn J Exp Med; 1974 Dec; 44(6):547-51. PubMed ID: 4477225
    [No Abstract] [Full Text] [Related]

  • 17. [Inhibition of specific binding activity of guinea pig complement C3 by dithiothreitol].
    Takahashi S, Tanaka K, Kono H, Takahashi M.
    Arerugi; 1972 Jan; 21(1):40-9. PubMed ID: 4623566
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.